United Therapeutics (UTHR) Tops Q4 EPS Views
Get Alerts UTHR Hot Sheet
Price: $229.72 -5.57%
EPS Growth %: +18.9%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: +18.9%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.68, $1.13 better than the analyst estimate of $2.55. Revenue for the quarter came in at $404.9 million versus the consensus estimate of $388.29 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Recruit Holdings Co., Ltd (6098:JP) (RCRUY) PT Raised to JPY7,800 at Jefferies, 'emerged stronger since the last earnings season'
- Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!